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Abstract: Indoles, dihydroisoquinolines and dihydroquinolines 
were efficiently prepared by ruthenium-catalyzed 
heterocyclizations of aromatic homo- and bis-homopropargyl 
amines/amides in the presence of an amine/ammonium base-
acid pair. These regioselective 5- and 6-endo cyclizations most 
probably occur by nucleophilic trapping of key Ru vinylidene 
intermediates. 
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Scheme 1 Ruthenium-Catalyzed Heterocyclization of Aromatic Homo- and Bis-Homopropargylic Amines/Amides: Formation of Indoles, 
Dihydroisoquinolines and Dihydroquinolines
Introduction 
The development of new methods for the synthesis of 
heterocyclic compounds continues to be a major 
challenge in modern organic synthesis.1 During the 
last few years, many transition metal-catalyzed 
heterocyclizations have been developed to achieve 
these goals.2 Specifically, the nucleophilic trapping  of 
metal vinylidene intermediates derived from terminal 
acetylenic compounds has been very succesful.3 
Oxygenated heterocycles, e.g. dihydrofurans and 
dihydropyrans, were prepared in a pioneer work 
developed by McDonald and coworkers from 
heterocyclizations (cycloisomerizations) of homo- and 
bis-homopropargylic alcohols using catalytic Mo and 
W vinylidenes.4 More advances in similar hetero- and 
oxidative cyclizations were later developed by Trost 
and Rhee using ruthenium5 and rhodium catalysts.6 
Seven-membered oxepines were recently synthesized 
by MacDonald and coworkers from heterocyclizations 
of preorganized alkynols using catalytic W 
vinylidenes.7 The corresponding benzofused 
derivatives, e.g. benzofurans and isochromenes, were 
synthesized by our own group on having used the 
regioselective 5-endo and 6-endo ruthenium-catalyzed 
heterocyclization of aromatic homo- and bis-
homopropargylic alcohols.8 More recently, even the 
more challenging seven-membered benzoxepines 
could also be synthesized by regioselective 7-endo 
heterocyclization of aromatic alkynols using in this 
case osmium catalysts.9 In the case of nitrogenated 
heterocycles, much effort has been devoted mainly to 
the synthesis of indoles. Since the pioneer work of 
McDonald using molybdenum catalysts,10 modern 
syntheses of indoles by heterocylization of substituted 
(2-ethynyl)anilines have been also described in Trost 
and Grotjahn groups using rhodium11 and ruthenium 
catalysts.12 Herein, we wish to report typical practical 
procedures, not only for the ruthenium-catalyzed 
synthesis of indoles, but to the six-membered 1,2-
dihydroisoquinolines and 1,4-dihydroquinolines by 
heterocyclization of aromatic homo- and bis-
homopropargyl amines/amides using commercial 
ruthenium catalysts.13 
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Scope and limitations 
The ruthenium-catalyzed 5-endo heterocyclization of 
2-(ethynyl)anilines 1 to indoles 2 was accomplished 
by heating at 90 ºC a solution of the corresponding 
ethynylaniline 1 and 10 mol% of commercial 
CpRu(PPh3)2Cl in pyridine (Table 1). The cyclization 
tolerates an unprotected amino group 1a and also 
electron-withdrawing substituents at the amino 
function, 1b and 1c, with similar yields being obtained 
(Table 1, entries 1–3). The tolerance of the cyclization 
was excellent with the different functional groups 
tested (nitro 1d, nitrile 1e, ester 1f,g) and gave good-
to-excellent yields of the corresponding indoles 2d–g 
(entries 4–7). Interestingly, cyclization seems more 
affected with the acid/base properties of the aniline 
rather than the electrophilicity of the vinylidene 
intermediates (entries 6 and 7). Internal alkyne such as 
2-(hexyn-1-yl)aniline 1h was not suitable for this 
reaction (entry 8), which seems to indicate that the 
cyclization does not involve simple alkyne activation 
with the catalyst. 
Table 1 Ru-catalyzed heterocyclization of 2-(ethynyl)anilines 1 
into indoles 2 





































































a Isolated yields. In all cases, conversion is higher than 97% (GC 
monitoring). 
The same procedure could be applied to the 
construction of 1,2-dihydroisoquinolines 4 from 
amide derivatives of 2-alkynylbenzylamines 3 (Table 
3). Even though the parent benzylamine 3a and its 
secondary derivatives N-(methyl) and N-
(phenyl)benzylamines failed to undergo 
heterocyclization, thus showing the important effect of 
the nature of the coordinating heteroatom, benzamide 
3b underwent smooth regioselective 6-endo 
heterocyclization to give isoquinolone 4b in fairly 
good isolated yield (entry 2). Furthermore, cyclization 
of secondary benzamide 3c also gave isoquinolone 4c 
in quite good yield, although a longer reaction time 
was required (entry 3). To further highlight the unique 
synthetic potential of this cycloisomerization, the 
pharmaceutically active chromophore benzothiazine 
1,1-dioxide 4d (benzosultam) was satisfactorily 
obtained from acyclic sulphonamide 3d (entry 4). By 
contrast, substituted benzamide 3e was not suitable for 
this reaction (entry 5), which again seems to indicate 
that the cyclization is not due to simple alkyne 
activation with the catalyst. Acetamide 3f and 
tosylamide 3g were smoothly cyclized to 1,2-
dihydroisoquinolines 4f and 4g, thus showing the 
versatility of the amide nucleophile in the substrates 
(entries 6 and 7). 
Table 2 Ru-catalyzed heterocyclization of aromatic bis-
homopropargyl amides 3 into 1,2-dihydroisoquinolines 4 







































































a Isolated yields. In all cases, conversion is higher than 97% (GC 
monitoring. 
Interestingly, the isomeric 2H-1,4-dihydroquinoline 6 
could also be prepared by 6-endo heterocyclization of 
unsubstituted 2-(2-propynyl)tosylanilide 5 in quite 


















Scheme 2 Ru-catalyzed heterocyclization of aromatic bis-
homopropargylic amide 5 into 1,4-dihydroquinoline 6. 
In summary, efficient Ru-catalyzed synthesis of 
indoles, 1,2-dihydroisoquinolines and 1,4-
dihydroquinoline by heterocyclization of aromatic 
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homo- and bis-homopropargyl amines/amides have 
been developed. Most probably, these regioselective 
processes (5- and 6-endo cyclizations) occur by 
nucleophilic trapping of key Ru vinylidene 
intermediates. The presence of an amine/ammonium 
base-acid pair accelerates the cyclization and 
facilitates the catalytic turnover. The new procedures 
to synthesize 1,2-dihydroisoquinolines and 1,4-
dihydroquinoline by C–N bond formation 
significantly increase the scope of metal vinylidene 
intermediates in catalytic processes. 
 
Procedures 
All reactions were carried out under an argon 
atmosphere in flame-dried glassware with magnetic 
stirring, unless otherwise noted. All starting materials 
were purchased from commercial suppliers and used 
without further purification, unless otherwise stated. 
Solvents were dried by distillation over an appropriate 
desiccant agent: tetrahydrofuran (THF) and diethyl 
ether (Et2O) were continuously refluxed and freshly 
distilled from sodium benzophenone ketyl under Ar; 
triethylamine (Et3N), pyridine (py) and 
dichloromethane (CH2Cl2) were continuously refluxed 
and freshly distilled from calcium hydride. Thin-layer 
chromatography (TLC) was carried out on silica-
coated aluminium plates (silica gel 60 F254 Merck) 
using UV light as visualizing agent (256 and 360 nm) 
and cerium molybdate (Hanessian’s stain, solution of 
12 g of ammonium molybdate, 0.5 g of ceric 
ammonium molybdate and 15 mL of conc. sulfuric 
acid in 235 mL of water), KMnO4 (solution of 1.5 g of 
potassium permanganate, 10 g of potassium 
bicarbonate and 1.25 mL of 10% sodium hydroxide in 
200 mL of water) or p-anisaldehyde (solution of 3.7 
mL of p-anisaldehyde, 1.5 mL of glacial acetic acid, 5 
mL of conc. sulfuric acid in 135 mL of absolute 
ethanol) with heat as developing agents. Flash 
chromatography was performed on silica gel 60 
(Merck, 230-400 mesh) with the indicated eluent. 1H 
and 13C NMR were recorded on Bruker DPX-250 
MHz, AMX-300 MHz, WM-500 MHz and Varian 
Inova-400 MHz instruments and chemical shifts are 
reported relative to tetramethylsilane as an internal 
reference. Coupling constants J are given in Hertz 
(Hz). Multiplicities are reported as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet or as a combination of them. Multiplicities 
of 13C NMR signals were determined by DEPT 
experiments. Gas chromatography (GC-MS) was 
recorded on an Agilent HP-6890N with a mass 
detector HP-5973N using a chemical ionization (CI) 
technique. High-resolution mass spectra (HRMS) was 
recorded on a Micromass Autospec spectrometer 
using CI (Chemical Ionization) or EI (Electron 
Ionization) techniques. Yields refer to isolated 
compounds estimated to be > 95% pure as determined 
by 1H NMR and capillary GC analysis. 
Starting materials 
General procedure for Sonogashira cross couplings 
Procedure 1: 
The corresponding alkyne (1.50 equiv) was added to a 
suspension of aryl iodide (1 equiv), PdCl2(PPh3)2 
(0.01 equiv) and CuI (0.03 equiv) in a 3:1 mixture of 
THF/Et3N (0.1 M). The reaction mixture was stirred at 
room temperature until disappearance of starting 
material (TLC and GC-MS monitoring). The mixture 
was filtered through silica gel and the filtrate was 
evaporated to dryness. The residue was dissolved in 
EtOAc and washed twice with brine. The combined 
organic layers were dried over anhydrous Na2SO4, 
filtered and evaporated under vacuum. The residue 
was purified by flash column chromatography through 
silica gel using a mixture of EtOAc/Hex as eluent to 
afford the corresponding cross coupling product. 
Procedure 2: 
The corresponding alkyne (1.50 equiv) was added to a 
suspension of aryl bromide (1 equiv), Pd(OAc)2 (0.05 
equiv), CuI (0.05 equiv) and PPh3 (0.1 equiv) in Et3N 
(0.1 M). The reaction mixture was heated at 90 ºC for 
24 h until disappearance of starting material (TLC and 
GC-MS monitoring). The mixture was filtered through 
silica gel and the filtrate was evaporated to dryness. 
The residue was dissolved in EtOAc and washed 
twice with brine. The combined organic layers were 
dried over anhydrous Na2SO4, filtered and evaporated 
under vacuum. The residue was purified by flash 
column chromatography through silica gel using a 
mixture of EtOAc/Hex as eluent to afford the 
corresponding cross coupling product. 
General procedure for desilylation of 
(trimethylsilyl)ethynyl derivatives. 
A solution of TBAF in THF (1M, 1.5 equiv) was 
added dropwise to a solution of (trimethylsilyl)ethynyl 
derivative (1 equiv) in THF. The reaction mixture was 
stirred at room temperature until disappearance of 
starting material (TLC and GC-MS monitoring). The 
reaction was quenched by adding brine and extracted 
three times with EtOAc. The combined organic layers 
were dried over anhydrous Na2SO4, filtered and 
evaporated under vacuum. The residue was purified 
by flash column chromatography through silica gel 
using a mixture of EtOAc/Hex as eluent to give the 
corresponding desilylated product. 
2-Ethynylaniline (1a) 
The general Sonogashira cross coupling procedure 1 
was followed using iodoaniline (0.60 g, 2.74 mmol), 
PdCl2(PPh3)2 (0.019 g, 0.027 mmol), CuI (0.016 g, 
0.082 mmol), trimethylsilylacetylene (0.40 g, 0.58 
mL, 4.11 mmol), THF (20 mL) and Et3N (7 mL). 
Upon completion (4 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of EtOAc/Hex as eluent 
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to give 2-[(trimethylsilyl)ethynyl]aniline (0.52 g, 
99%) as a brown oil. 
1H NMR (250 MHz, CDCl3): δ = 7.26 (d, J = 7.7 Hz, 
1H), 7.05 (t, J = 7.7, 1H), 6.61 (t, J = 7.7 Hz, 2H), 
4.18 (s, 2H), 0.24 (s, 9H)). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 148.1 (C), 
132.0 (CH), 129.8 (CH), 117.6 (CH), 114.1 (CH), 
107.5 (C), 101.8 (C), 99.5 (C), 0.0 (3 x CH3). 
MS (CI): m/z (%) = 190 (M++1, 100), 174 (52), 73 
(20). 
HRMS-CI: m/z calcd for C11H16NSi [M++1]: 
190.1052; found: 190.1052. 
The general desilylation procedure was followed 
using 2-[(trimethylsilyl)ethynyl]aniline (0.49 g, 2.59 
mmol), a solution of TBAF in THF (1M, 3.89 mL) 
and THF (25 mL). Upon completion (10 min) and 
work-up, the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to give 1a (0.29 g, 97%) as a 
brown oil. 
1H NMR (250 MHz, CDCl3): δ = 7.31 (d, J = 7.7 Hz, 
1H), 7.13 (t, J = 7.7 Hz, 1H), 6.71-6.62 (m, 2H), 4.23 
(s, 2H), 3.37 (s, 1H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 148.5 (C), 
132.5 (CH), 130.1 (CH), 117.7 (CH), 114.2 (CH), 
106.5 (C), 82.4 (CH), 80.6 (C). 
MS (CI): m/z (%) = 118 (M++1, 100), 91 (2). 





A solution of methanesulfonyl chloride (0.57 g, 0.39 
mL, 5.02 mmol) in THF (2.5 mL) was added dropwise 
to a solution of iodoaniline (1 g, 4.56 mmol), pyridine 
(0.76 g, 0.77 mL, 9.58 mmol) in THF (10 mL) under 
Ar. The solution was stirred at room temperature for 
12 h until disappearance of starting material (TLC, 
GC-MS monitoring). The resulting mixture was 
evaporated under vacuum and the residue was purified 
by flash column chromatography through silica gel 
using a 2:8 mixture of EtOAc/Hex as eluent to afford 
N-(2-iodophenyl)methanesulfonamide (1.22 g, 90%) 
as a yellowish solid. 
1H NMR (250 MHz, CDCl3): δ = 7.82 (d, J = 7.7 Hz, 
1H), 7.63 (d, J = 7.9 Hz, 1H), 7.37 (t, J = 7.4 Hz, 1H) 
6.93 (t, J = 7.44 Hz, 1 H), 6.74 (s, br, 1H), 3.02 (s, 
3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 139.3 (CH), 
137.5 (C), 129.7 (CH), 127.2 (CH), 122.5 (CH), 92.2 
(C), 40.1 (CH3). 
MS (EI, 70 eV): m/z (%) = 297 (M+, 17), 218 (49), 
170 (5), 108 (21), 91 (100). 
The general Sonogashira cross coupling procedure 1 
was followed using N-(2-
iodophenyl)methanesulfonamide (1.20 g, 4.04 mmol), 
PdCl2(PPh3)2 (0.028 g, 0.040 mmol), CuI (0.023 g, 
0.12 mmol), trimethylsilylacetylene (0.59 g, 0.85 mL, 
6.06 mmol), THF (30 mL) and Et3N (10 mL). Upon 
completion (12 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:5 mixture of EtOAc/Hex as eluent 
to give N-(2-
((trimethylsilyl)ethynyl)phenyl)methanesulfonamide 
(1.02 g, 95 %) as a colorless solid. 
1H NMR (300 MHz, CDCl3): δ = 7.58 (d, J = 7.7 Hz, 
1H), 7.47 (dd, J = 7.7, 1.4 Hz, 1H), 7.36 (td, J = 7.7, 
1.4 Hz, 1H), 7.12 (td, J = 7.7, 1.4 Hz, 1H), 7.00 (s, br, 
1H), 3.00 (s, 3H), 0.29 (s, 9H). 
MS (EI, 70 eV): m/z (%) = 267 (M+, 69), 252 (100). 
HRMS-EI: m/z calcd for C12H17NO2SSi [M+]: 
267.0750; found: 267.0719. 
The general desilylation procedure was followed 
using N-(2-
((trimethylsilyl)ethynyl)phenyl)methanesulfonamide 
(1.00 g, 3.74 mmol), a solution of TBAF in THF (1M, 
5.61 mL) and THF (30 mL). Upon completion (10 
min) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 3:7 
mixture of EtOAc/Hex as eluent to give 1b (0.62 g, 
85%) as a yellow solid. 
1H NMR (300 MHz, CDCl3) δ (ppm): 7.61 (d, J = 
8.26 Hz, 1H), 7.51 (d, J = 7.66 Hz, 1H), 7.39 (t, J = 
7.84 Hz, 1H), 7.14 (t, J = 7.58Hz, 1H), 7.03 (s, 1H), 
3.50 (s, 1H), 3.03 (s, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 138.6 
(C), 132.8 (CH), 130.5 (CH), 124.7 (CH), 119.5 (CH), 
112.9 (C), 84.9 (CH), 78.6 (C), 39.7 (CH3). 





A solution of 4-methylbenzene-1-sulfonyl chloride 
(3.97 g, 20.54 mmol) in THF (10 mL) was added 
dropwise over 2 h to a solution of iodoaniline (4.50 g, 
20.54 mmol), pyridine (1.70 g, 1.74 mL, 21.54 mmol) 
in THF (30 mL) under Ar. The solution was stirred at 
room temperature for 12 h until disappearance of 
starting material (TLC, GC-MS monitoring). The 
resulting mixture was evaporated under vacuum and 
the residue was purified by flash column 
chromatography through silica gel using a 1:9 mixture 
of EtOAc/Hex as eluent to afford N-(2-iodophenyl)-4-
methylbenzenesulfonamide (7.50 g, 98%) as a white 
solid. 
1H NMR (250 MHz, CDCl3): δ = 7.60 (m, 4H), 7.28 
(td, J = 8.2, 1.3 Hz, 1H), 7.19 (d, J = 8.2 Hz, 2H), 6.88 
(s, 1H), 6.80 (td, J = 7.7, 1.3 Hz, 1H), 2.34 (s, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 144.22 (C), 
139.09 (CH), 137.40 (C), 135.79 (C), 129.63 (2xCH), 
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129.45 (CH), 127.39 (2xCH), 126.90 (CH), 122.50 
(CH), 92.47 (C), 21.58 (CH3). 
MS (CI): m/z (%) = 374 (M++1, 100), 247 (92), 246 
(25), 219 (18). 
The general Sonogashira cross coupling procedure 1 
was followed using N-(2-iodophenyl)-4-
methylbenzenesulfonamide (3.00 g, 8.05 mmol), 
PdCl2(PPh3)2 (0.056 g, 0.080 mmol), CuI (0.045 g, 
0.024 mmol), trimethylsilylacetylene (1.18 g, 1.70 
mL, 12.06 mmol), THF (60 mL) and Et3N (20 mL). 
Upon completion (12 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 2:8 mixture of EtOAc/Hex as eluent 
to give 4-methyl-N-(2-
((trimethylsilyl)ethynyl)phenyl)benzenesulfonamide 
(2.51 g, 91 %) as a yellow solid. 
1H NMR (250 MHz, CDCl3): δ = 7.35 (t, J = 8.4 Hz, 
3H), 6.98 (m, 3H), 6.90 (d, J = 8.4 Hz, 2H), 6.70 (t, J 
= 7.6 Hz, 1H), 2.06 (s, 3H), 0.008 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 144.01 (C), 
138.07 (C), 135.98 (C), 131.96 (CH), 129.81 (CH), 
129.58 (2xCH), 127.20 (2xCH), 124.33 (CH), 119.72 
(CH), 114.19 (C), 102.23 (C), 99.51 (C), 21.52 (CH3), 
-0.13 (3xCH3). 
MS (CI): m/z (%) = 344 (M++1, 100), 328 (19). 
The general desilylation procedure was followed 
using 4-methyl-N-(2-
((trimethylsilyl)ethynyl)phenyl)benzenesulfonamide 
(1.79 g, 5.22 mmol), a solution of TBAF in THF (1M, 
7.82 mL) and THF (50 mL). Upon completion (10 
min) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 2:8 
mixture of EtOAc/Hex as eluent to give 1c (1.30 g, 
92%) as a yellow oil. 
1H NMR (250 MHz, CDCl3): δ = 7.70 (d, J = 8.2 Hz, 
2H), 7.60 (d, J = 8.2 Hz, 1H), 7.33 (t, J = 7.7 Hz, 2H), 
7.24 (d, J = 8.2 Hz, 2H), 7.02 (t, J = 7.7 Hz, 1H), 3.30 
(s, 1H), 2.37 (s, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 144.22 (C), 
138.52 (C), 135.98 (C), 132.59 (CH), 130.24 (CH), 
129.74 (2xCH), 127.42 (2xCH), 124.26 (CH), 119.37 
(CH), 112.76 (C), 84.55 (CH), 78.66 (C), 21.65 (CH3). 
MS (CI): m/z (%) = 272 (M++1, 100), 118 (21). 
4-Nitro-2-[(trimethylsilyl)ethynyl]aniline (1d) 
The general Sonogashira cross coupling procedure 1 
was followed using 2-iodo-4-nitroaniline (0.60 g, 2.27 
mmol), PdCl2(PPh3)2 (0.016 g, 0.023 mmol), CuI 
(0.013 g, 0.069 mmol), trimethylsilylacetylene (0.33 
g, 0.48 mL, 3.40 mmol), THF (16 mL) and Et3N (6 
mL). Upon completion (12 h) and work-up, the 
residue was purified by flash column chromatography 
through silica gel using a 1:4 mixture of EtOAc/Hex 
as eluent to give 4-nitro-2-
[(trimethylsilyl)ethynyl+aniline (0.49 g, 93 %) as a 
yellow solid. 
1H NMR (250 MHz, CDCl3): δ = 8.22 (d, J = 2.6 Hz, 
1H), 8.01 (dd, J = 9.0, 2.6 Hz, 1H), 6.67 (d, J = 9.0 
Hz, 1H), 4.96 (s, 2H), 0.28 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 153.3 (C), 
138.1 (C), 128.9 (CH), 126.1 (CH), 112.7 (CH), 106.9 
(C), 102.1 (C), 98.9 (C), -0.1 (3 x CH3). 
MS (CI): m/z (%) = 235 (M++1, 100), 219 (69), 205 
(83), 189 (52), 73 (35). 
HRMS-CI: m/z calcd for C11H15N2O2Si [M++1]: 
235.0903; found: 235.0903. 
The general desilylation procedure was followed 
using 4-nitro-2-[(trimethylsilyl)ethynyl]aniline (0.40 
g, 1.71 mmol), a solution of TBAF in THF (1M, 2.56 
mL) and THF (15 mL). Upon completion (10 min) 
and work-up, the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to give 1d (0.18 g, 63%) as a 
yellow solid. 
1H NMR (300 MHz, CDCl3): δ = 8.25 (s, 1H), 8.04 (d, 
J = 9.0 Hz, 1H), 6.68 (d, J = 9.0 Hz, 1H), 5.00 (s, 2H), 
3.47 (s, 1H). 
13C NMR, DEPT (75 MHz, CDCl3): δ = 153.5 (C), 
137.3 (C), 129.3 (CH), 126.4 (CH), 112.9 (CH), 105.7 
(C), 84.2 (CH), 78.1 (C). 
MS (EI, 70 eV): m/z (%) = 162 (M+, 100), 132 (40), 
116 (24), 89 (97), 63 (45), 58 (35). 
HRMS-EI: m/z calcd for C8H6N2O [M+]: 162.0429; 
found: 162.0429. 
4-Amino-3-ethynylbenzonitrile (1e) 
The general Sonogashira cross coupling procedure 1 
was followed using 4-amino-3-iodobenzonitrile (1.50 
g, 6.15 mmol), PdCl2(PPh3)2 (0.043 g, 0.061 mmol), 
CuI (0.035 g, 0.18 mmol), trimethylsilylacetylene 
(0.91 g, 1.30 mL, 9.22 mmol), THF (45 mL) and Et3N 
(15 mL). Upon completion (12 h) and work-up, the 
residue was purified by flash column chromatography 
through silica gel using a 1:4 mixture of EtOAc/Hex 
as eluent to give 4-amino-3-
[(trimethylsilyl)ethynyl]benzonitrile (1.18 g, 90 %) as 
a yellow solid. 
1H NMR (250 MHz, CDCl3): δ = 7.56 (d, J = 1.8 Hz, 
1H), 7.33 (dd, J = 8.5, 1.8 Hz, 1H), 6.68 (d, J = 8.5 
Hz, 1H), 4.79 (s, 2H), 0.27 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 151.4 (C), 
136.4 (CH), 133.3 (CH), 119.3 (C), 113.8 (CH), 107.9 
(C), 102.0 (C), 99.7 (C), 98.9 (C), -0.1 (3 x CH3). 
MS (CI): m/z (%) = 215 (M++1, 100), 199 (70), 73 
(17). 
HRMS-CI: m/z calcd for C12H15N2Si [M++1]: 
215.1005; found: 215.1005. 
The general desilylation procedure was followed 
using 4-amino-3-[(trimethylsilyl)ethynyl]benzonitrile 
(0.80 g, 3.74 mmol), a solution of TBAF in THF (1M, 
3.60 mL) and THF (35 mL). Upon completion (10 
min) and work-up, the residue was purified by flash 
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column chromatography through silica gel using a 3:7 
mixture of EtOAc/Hex as eluent to give 1e (0.45 g, 
84%) as a yellow solid. 
1H NMR (300 MHz, CDCl3): δ = 7.57 (s, 1H), 7.36 (d, 
J = 8.5 Hz, 1H), 6.70 (d, J = 8.5 Hz, 1H), 4.85 (s, 2H), 
3.46 (s, 1H). 
13C NMR, DEPT (75 MHz, CDCl3): δ = 151.8 (C), 
136.8 (CH), 133.5 (CH), 119.2 (C), 114.0 (CH), 106.6 
(C), 99.6 (C), 84.2 (CH), 78.1 (C). 
MS (EI, 70 eV): m/z (%) = 142 (M+, 100), 115 (66), 
62 (18). 
HRMS-EI: m/z calcd for C9H6N2 [M+]: 142.0531; 
found: 142.0531. 
Methyl 4-amino-3-ethynylbenzoate (1f) 
The general Sonogashira cross coupling procedure 1 
was followed using methyl 4-amino-3-iodobenzoate 
(1.00 g, 3.61 mmol), PdCl2(PPh3)2 (0.025 g, 0.036 
mmol), CuI (0.021 g, 0.11 mmol), 
trimethylsilylacetylene (0.53 g, 0.77 mL, 5.42 mmol), 
THF (27 mL) and Et3N (9 mL). Upon completion (12 
h) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 3:7 
mixture of EtOAc/Hex as eluent to give methyl 4-
amino-3-[(trimethylsilyl)ethynyl]benzoate (0.78 g, 87 
%) as a yellow solid. 
1H NMR (250 MHz, CDCl3): δ = 8.00 (s, 1H), 7.78 (d, 
J = 8.6 Hz, 1H), 6.65 (d, J = 8.6 Hz, 1H), 4.68 (s, 2H), 
3.84 (s, 3H), 0.26 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 166.5 (C=O), 
151.8 (C), 134.5 (CH), 131.5 (CH), 119.1 (C), 113.1 
(CH), 106.9 (C), 100.5 (C), 100.4 (C), 51.7 (CH3), -
0.1 (3 x CH3). 
MS (CI): m/z (%) = 248 (M++1, 100), 232 (28), 185 
(26), 144 (17), 57 (64). 
HRMS-CI: m/z calcd for C13H18NO2Si [M++1]: 
248.1107; found: 248.1107. 
The general desilylation procedure was followed 
using methyl 4-amino-3-
[(trimethylsilyl)ethynyl]benzoate (0.49 g, 2.00 mmol), 
a solution of TBAF in THF (1M, 3.00 mL) and THF 
(20 mL). Upon completion (10 min) and work-up, the 
residue was purified by flash column chromatography 
through silica gel using a 1:4 mixture of EtOAc/Hex 
as eluent to give 1f (0.34 g, 97%) as a yellow solid. 
1H NMR (300 MHz, CDCl3): δ = 8.03 (s, 1H), 7.80 (d, 
J = 8.6, 1H), 6.67 (d, J = 8.6 Hz, 1H), 4.76 (s, 2H), 
3.84 (s, 3H), 3.41 (s, 1H). 
13C NMR, DEPT (75 MHz, CDCl3): δ = 166.4 (C=O), 
152.2 (C), 134.8 (CH), 131.7 (CH), 119.0 (C), 113.2 
(CH), 105.6 (C), 82.9 (CH), 79.4 (C), 51.6 (CH3). 
MS (CI): m/z (%) = 176 (M++1, 100), 144 (12). 
HRMS-EI: m/z calcd for C10H9NO2 [M+]: 175.0633; 
found: 175.0633. 
Methyl 3-amino-4-ethynylbenzoate (1g) 
The general Sonogashira cross coupling procedure 1 
was followed using methyl 3-amino-4-iodobenzoate 
(1.00 g, 3.61 mmol), PdCl2(PPh3)2 (0.025 g, 0.036 
mmol), CuI (0.021 g, 0.11 mmol), 
trimethylsilylacetylene (0.53 g, 0.77 mL, 5.42 mmol), 
THF (27 mL) and Et3N (9 mL). Upon completion (12 
h) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 3:7 
mixture of EtOAc/Hex as eluent to give methyl 3-
amino-4-((trimethylsilyl)ethynyl)benzoate (0.86 g, 90 
%) as a colorless solid. 
1H NMR (500 MHz, CDCl3): δ = 7.30-7.36 (m, 3H), 
4.34 (s, 2H), 3.88 (s, 3H), 0.27 (s, 9H. 
13C NMR (125 MHz, CDCl3): δ = 166.8 (C=O), 
148.1, 132.2, 131.0, 118.6, 114.9, 112.0, 102.7, 100.9, 
52.1, 0.00. 
The general desilylation procedure was followed 
using methyl 3-amino-4-
((trimethylsilyl)ethynyl)benzoate (0.49 g, 2.00 mmol), 
a solution of TBAF in THF (1M, 3.00 mL) and THF 
(20 mL). Upon completion (10 min) and work-up, the 
residue was purified by flash column chromatography 
through silica gel using a 1:4 mixture of EtOAc/Hex 
as eluent to give 1g (0.33 g, 95%) as a yellow solid. 
1H NMR (300 MHz, CDCl3): δ = 7.40-7.29 (m, 3H), 
4.41 (s, br, 2H), 3.88 (s, 3H), 3.52 (s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 166.8 (C=O), 148.4, 
132.5, 131.3, 118.5, 115.1, 110.7, 84.9, 79.9, 52.2. 
MS (EI, 70 eV): m/z (%) = 175 (M+, 100), 144 (46), 
116 (22), 89 (14). 
2-(Hex-1-yn-1-yl)aniline (1h) 
The general Sonogashira cross coupling procedure 1 
was followed using 2-iodoaniline (0.50 g, 2.28 mmol), 
PdCl2(PPh3)2 (0.048 g, 0.068 mmol), CuI (0.026 g, 
0.14 mmol), hex-1-yne (0.28 g, 0.39 mL, 3.42 mmol), 
THF (16 mL) and Et3N (6 mL). Upon completion (12 
h) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 1:4 
mixture of EtOAc/Hex as eluent to give 1h (0.34 g, 87 
%) as a yellowish oil. 
1H NMR (250 MHz, CDCl3): δ = 7.23 (dd, J = 7.8, 1.3 
Hz, 1H), 7.09-7.00 (m, 1H), 6.69-6.58 (m, 2H), 4.13 
(s, 2H), 2.44 (t, J = 6.9 Hz, 2H), 1.64-1.40 (m, 4H), 
0.93 (t, J = 7.1 Hz, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 147.5 (C), 
131.8 (CH), 128.6 (CH), 117.6 (CH), 114.0 (CH), 
108.7 (C), 95.5 (C), 76.9 (C), 30.8 (CH2), 21.9 (CH2), 
19.1 (CH2), 13.5 (CH3). 
MS (CI): m/z (%) = 174 (M++1, 100), 132 (10), 57 
(17). 
HRMS-CI: m/z calcd for C12H16N [M++1]: 174.1283; 
found: 174.1283. 
(2-Ethynylphenyl)methanamine (3a) 
The general Sonogashira cross coupling procedure 1 
was followed using 2-iodobenzonitrile (1.50 g, 6.55 
mmol), PdCl2(PPh3)2 (0.046 g, 0.066 mmol), CuI 
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(0.038 g, 0.20 mmol), trimethylsilylacetylene (0.96 g, 
1.39 mL, 9.82 mmol), THF (48 mL) and Et3N (16 
mL). Upon completion (12 h) and work-up, the 
residue was purified by flash column chromatography 
through silica gel using a 0.5:9.5 mixture of 
EtOAc/Hex as eluent to give 2-
[(trimethylsilyl)ethynyl]benzonitrile (1.29 g, 99 %) as 
a brown oil. 
1H NMR (250 MHz, CDCl3): δ = 7.35-7.18 (m, 3H), 
7.15-7.05 (m, 1H), 0.00 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 132.0 (CH), 
131.9 (CH), 131.8 (CH), 128.2 (CH), 126.2 (C), 116.6 
(C), 115.2 (C), 101.4 (C), 100.2 (C), -0.8 (3 x CH3). 
MS (CI): m/z (%) = 200 (M++1, 100), 184 (56), 128 
(11). 
The general desilylation procedure was followed 
using 2-[(trimethylsilyl)ethynyl]benzonitrile (1.00 g, 
5.05 mmol), a solution of TBAF in THF (1M, 7.54 
mL) and THF (50 mL). Upon completion (10 min) 
and work-up, the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to give 2-ethynylbenzonitrile 
(0.49 g, 76%) as a white solid. 
A solution of 2-ethynylbenzonitrile (0.20 g, 1.57 
mmol) in Et2O (0.70 mL) was added dropwise  into a 
suspension of LiAlH4 (0.12 g, 3.15 mmol) in Et2O 
(2.30 mL) at -10 ºC. The resultant slurry was stirred at 
-10 ºC for 1 h and, then, at room temperature for 
another 1 h. The reaction was quenched by the careful 
dropwise addition of H2O (0.2 mL) followed by a 
saturated solution of NaOH (0.2 mL). The resultant 
biphasic mixture was stirred vigourously for 2 h at 
room temperature. The layers were then allowed to 
separate and the aqueous layer was extracted with 
additional Et2O (2 mL). The combined organic layers 
were washed with brine (15 mL), dried (anhydrous 
Na2SO4), filtered over Celite and concentrated under 
vacuum to afford 3a (0.16 g, 76%) as a brown oil. 
1H NMR (250 MHz, CDCl3): δ = 7.48 (d, J = 7.5 Hz, 
1H), 7.34-7.28 (m, 2H), 7.23-7.16 (m, 1H), 3.96 (s, 
2H), 3.32 (s, 1H), 1.61 (s, 2H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 145.8 (C), 
132.9 (CH), 129.1 (CH), 127.2 (CH), 126.6 (CH), 
120.5 (C), 82.7 (C), 81.5 (CH), 45.2 (CH2). 
MS (CI): m/z (%) = 132 (M++1, 100), 115 (92). 
2-Ethynylbenzamide (3b) 
The general Sonogashira cross coupling procedure 2 
was followed using 2-bromobenzamide (2.00 g, 10 
mmol), Pd(OAc)2 (0.11 g, 0.50 mmol), CuI (0.095 g, 
0.50 mmol), PPh3 (0.26 g, 1.00 mmol), 
trimethylsilylacetylene (1.47 g, 2.12 mL, 15 mmol) 
and Et3N (80 mL). Upon completion (24 h) and work-
up, the residue was purified by flash column 
chromatography through silica gel using a 2:3 mixture 
of  EtOAc/Hex as eluent to give 2-
[(trimethylsilyl)ethynyl]benzamide (0.69 g, 32%) as a 
yellow solid. 
The general desilylation procedure was followed 
using 2-[(trimethylsilyl)ethynyl]benzamide (0.60 g, 
2.76 mmol), a solution of TBAF in THF (1M, 4.15 
mL) and THF (25 mL). Upon completion (10 min) 
and work-up, the residue was purified by flash column 
chromatography through silica gel using a 1:1 mixture 
of EtOAc/Hex as eluent to give 3b (0.17 g, 42%) as a 
yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 8.09-8.06 (m, 1H), 
7.62-7.58 (m, 1H), 7.48-7.44 (m, 2H), 6.44 (s, 2H), 
3.53 (s, 1H). 
13C NMR, DEPT (100 MHz, CDCl3): δ = 168.0 
(C=O), 135.4 (C), 134.2 (CH), 130.9 (CH), 130.1 
(CH), 129.4 (CH), 118.9 (C), 83.9 (CH), 82.3 (C). 
MS (EI, 70 eV): m/z (%) = 145 (M+, 91), 129 (40), 
117 (35), 101 (80), 75 (56). 
HRMS-EI: m/z calcd for C9H7NO [M+]: 145.0528; 
found: 145.0528. 
N-butyl-2-ethynylbenzamide (3c) 
In a flamed flame-dried round-bottomed flask under 
Ar 2-iodobenzoic acid (1.49 g, 6.00 mmol) was 
introduced and then thionyl chloride (7.14 g, 4.35 mL, 
60 mmol) was added dropwise. The mixture was 
stirred at room temperature for 12 h (NMR 
monitoring) until no gas emission was observed. 
Excess SOCl2 was removed in vacuo. The crude 2-
iodobenzoyl chloride (1.35 g, 84%) as a white solid 
was then used without further purification. 
1H NMR (250 MHz, CDCl3): δ = 8.12-8.00 (m, 2H), 
7.50 (m, J = 7.6 Hz, 1H), 7.26 (t, J = 7.6 Hz, 1H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 167.0 (C=O), 
141.9 (CH), 137.7 (C), 134.4 (CH), 133.4 (CH), 128.2 
(CH), 93.8 (C). 
A solution of 2-iodobenzoyl chloride (1.30 g, 4.89 
mmol) in CH2Cl2 (25 mL) was added dropwise to a 
mixture of butan-1-amine (0.32 g, 0.44 mL, 4.42 
mmol), Et3N (0.54 g, 0.74 mL, 5.33 mmol) in CH2Cl2 
(25 mL) under Ar. The solution was stirred at room 
temperature for 12 h until disappearance of starting 
material (TLC, GC-MS monitoring). The resulting 
mixture was filtered by gravity, washed with H2O (2 x 
25 mL), dried over anhydrous Na2SO4, filtered and 
evaporated under vacuum. The residue was purified 
by flash column chromatography through silica gel 
using a 1:9 mixture of EtOAc/Hex as eluent to afford 
N-butyl-2-iodobenzamide (0.75 g, 50%) as a yellow 
solid. 
1H NMR (250 MHz, CDCl3): δ = 7.83 (d, J = 7.9 Hz, 
1H), 7.35 (d, J = 4.3 Hz, 2H), 7.13-7.02 (m, 1H), 5.93 
(s, 1H), 3.47-3.37 (m, 2H), 1.68-1.54 (m, 2H), 1.51-
1.35 (m, 2H), 0.96 (t, J = 7.3 Hz, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 169.3 (C=O), 
142.4 (C), 139.7 (CH), 130.9 (CH), 128.1 (CH), 128.0 
(CH), 92.4 (C), 39.7 (CH2), 31.4 (CH2), 20.1 (CH2), 
13.7 (CH3). 
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The general Sonogashira cross coupling procedure 1 
was followed using N-butyl-2-iodobenzamide (0.70 g, 
2.31 mmol), PdCl2(PPh3)2 (0.084 g, 0.12 mmol), CuI 
(0.023 g, 0.12 mmol), trimethylsilylacetylene (0.34 g, 
0.49 mL, 3.46 mmol), THF (17 mL) and Et3N (6 mL). 
Upon completion (4 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 3:7 mixture of EtOAc/Hex as eluent 
to give N-butyl-2-[(trimethylsilyl)ethynyl]benzamide 
(0.62 g, 98 %) as a yellowish oil. 
1H NMR (250 MHz, CDCl3): δ = 8.18-8.06 (m, 1H), 
7.69 (s, 1H), 7.59-7.51 (m, 1H), 7.50-7.37 (m, 2H), 
3.57-3.43 (m, 2H), 1.69-1.57 (m, 2H), 1.54-1.38 (m, 
2H), 0.97 (t, J = 7.2 Hz, 3H), 0.29 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 165.7 (C=O), 
135.4 (C), 133.9 (CH), 130.2 (CH), 130.1 (CH), 129.0 
(CH), 119.1 (C), 103.6 (C), 101.4 (C), 39.8 (CH2), 
31.6 (CH2), 20.3 (CH2), 13.8 (CH3), -0.3 (3 x CH3). 
MS (CI): m/z (%) = 274 (M++1, 100), 194 (23), 126 
(41). 
HRMS (ESI): m/z calcd for C16H24NOSi [M++1]: 
274.1627; found: 274.1622. 
The general desilylation procedure was followed 
using N-butyl-2-[(trimethylsilyl)ethynyl]benzamide 
(0.60 g, 2.20 mmol), a solution of TBAF in THF (1M, 
3.30 mL) and THF (22 mL). Upon completion (10 
min) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 3:7 
mixture of EtOAc/Hex as eluent to give 3c (0.27 g, 
61%) as a yellow solid. 
1H NMR (250 MHz, CDCl3): δ = 7.92-7.87 (m 1H), 
7.56-7.50 (m, 1H), 7.43-7.35 (m, 2H), 7.28 (s, 1H), 
3.50 (s, 1H), 3.47-3.42 (m, 2H), 1.67-1.54 (m, 2H), 
1.45-1.37 (m, 2H), 0.95 (t, J = 7.2 Hz, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 166.0 (C=O), 
136.8 (C), 133.9 (CH), 130.0 (CH), 129.3 (CH), 129.0 
(CH), 118.2 (C), 83.1 (CH), 82.0 (C), 39.6 (CH2), 31.1 
(CH2), 20.0 (CH2), 13.6 (CH3). 
MS (CI): m/z (%) = 202 (M++1, 100), 146 (11), 126 
(18), 110 (14), 85 (8). 
HRMS (ESI): m/z calcd for C13H16NO [M++1]: 
202.1232; found: 202.1226. 
N-butyl-2-ethynylbenzenesulfonamide (3d) 
Butan-1-amine (0.45 g, 0.61 mL, 6.18 mmol) was 
added dropwise to a solution of 2-bromobenzene-1-
sulfonyl chloride (0.56 g, 2.21 mmol) in CHCl3 (20 
mL) cooled at 0 ºC. The resulting solution was then 
stirred at room temperature for 2 h until disappearance 
of starting material (TLC, GC-MS monitoring). The 
reaction mixture was evaporated under vacuum and 
the residue was dissolved in Et2O (10 mL), washed 
with brine (2 x 10 mL), dried over anhydrous Na2SO4, 
filtered and evaporated under vacuum. The resulting 
residue was purified by flash column chromatography 
through silica gel using a 3:7 mixture of EtOAc/Hex 
as eluent to give 2-bromo-N-butylbenzenesulfonamide 
(0.52 g, 50%) as a white solid. 
1H NMR (250 MHz, CDCl3): δ = 8.15 (d, J = 7.3 Hz, 
1H), 7.74 (d, J = 7.4 Hz, 1H), 7.53-7.39 (m, 2H), 5.21 
(s, 1H), 2.91 (dd, J = 13.3, 6.7 Hz, 2H), 1.52-1.22 (m, 
4H), 0.84 (t, J = 7.2 Hz, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 138.6 (C), 
134.9 (CH), 133.6 (CH), 131.5 (CH), 127.7 (CH), 
119.5 (C), 43.0 (CH2), 31.3 (CH2), 20.0 (CH2), 13.4 
(CH3). 
MS (CI): m/z (%) = 292 (M++1, 100), 238 (13), 236 
(13), 72 (7). 
The general Sonogashira cross coupling procedure 2 
was followed using 2-bromo-N-
butylbenzenesulfonamide (0.50 g, 1.72 mmol), 
Pd(OAc)2 (0.060 g, 0.086 mmol), CuI (0.016 g, 0.086 
mmol), PPh3 (0.045 g, 0.017 mmol), 
trimethylsilylacetylene (0.253 g, 0.36 mL, 2.58 mmol) 
and Et3N (17 mL). Upon completion (12 h) and work-
up, the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to give N-butyl-2-
[(trimethylsilyl)ethynyl]benzenesulfonamide (0.23 g, 
43%) as a yellowish oil. 
1H NMR (250 MHz, CDCl3): δ = 7.79 (d, J = 7.3 Hz, 
1H), 7.41 (d, J = 7.5 Hz, 1H), 7.34-7.20 (m, 2H), 5.09 
(t, J = 6.0 Hz, 1H), 2.67-2.63 (m, 2H), 1.30-1.00 (m, 
4H), 0.63 (t, J = 7.3 Hz, 3H), 0.08 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 141.0 (C), 
134.3 (CH), 131.9 (CH), 128.8 (CH), 128.7 (CH), 
119.8 (C), 103.5 (C), 101.4 (C), 42.8 (CH2), 31.2 
(CH2), 19.6 (CH2), 13.3 (CH3), -0.6 (3 x CH3). 
MS (CI): m/z (%) = 310 (M++1, 100), 294 (20). 
HRMS-CI: m/z calcd for C15H24NO2SSi [M++1]: 
310.1297; found: 310.1298. 
A solution of TBAF in THF (1M, 5 mL) was added 
dropwise to a solution of N-butyl-2-
[(trimethylsilyl)ethynyl]benzenesulfonamide (0.22 g, 
0.71 mmol) in THF (5 mL) cooled at -78 ºC. The 
reaction mixture was stirred at -78 ºC for 2 h until 
disappearance of starting material (TLC and GC-MS 
monitoring). The reaction was quenched by adding a 
saturated solution of citric acid. The resulting mixture 
was extracted with Et2O (3 x 5 mL) and washed with 
H2O (2 x 5 mL) and a saturated solution of NaHCO3 
(2 x 5 mL). The combined organic layers were dried 
over anhydrous Na2SO4, filtered and evaporated under 
vacuum. The residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to afford 3d (0.15 g, 88%) as 
a brown solid. 
1H NMR (250 MHz, CDCl3): δ = 8.08-8.02 (m, 1H), 
7.72-7.66 (m, 1H), 7.59-7.47 (m, 2H), 5.21 (t, J = 5.6 
Hz, 1H), 3.66 (s, 1H), 2.90 (dd, J = 13.3, 6.6 Hz, 2H), 
1.52-1.24 (m, 4H), 0.85 (t, J = 7.2 Hz, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 141.4 (C), 
135.1 (CH), 132.0 (CH), 129.2 (CH), 129.1 (CH), 
119.2 (C), 85.7 (CH), 80.2 (C), 43.0 (CH2), 31.4 
(CH2), 19.6 (CH2), 13.4 (CH3). 
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MS (CI): m/z (%) = 238 (M++1, 100), 182 (15). 
HRMS-CI: m/z calcd for C12H16NO2S [M++1]: 
238.0902; found: 238.0896. 
2-(Hex-1-yn-1-yl)benzamide (3e) 
The general Sonogashira cross coupling procedure 2 
was followed using 2-bromobenzamide (1.00 g, 5.00 
mmol), Pd(OAc)2 (0.056 g, 0.25 mmol), CuI (0.048 g, 
0.25 mmol), PPh3 (0.13 g, 0.50 mmol), 1-hexyne 
(0.62 g, 0.86 mL, 7.50 mmol) and Et3N (40 mL). 
Upon completion (24 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:1 mixture of EtOAc/Hex as eluent 
to afford 3e (0.18 g, 18%) as a brown solid. 
1H NMR (250 MHz, CDCl3): δ = 8.18-8.01 (m, 1H), 
7.77-7.31 (m, 5H), 2.46 (t, J = 7.0 Hz, 2H), 1.68-1.40 
(m, 4H), 0.94 (t, J = 7.1 Hz, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 168.7 (C=O), 
134.1 (C), 133.5 (CH), 130.6 (CH), 129.8 (CH), 127.8 
(CH), 120.8 (C), 97.6 (C), 79.3 (C), 30.2 (CH2), 21.8 
(CH2), 19.1 (CH2), 13.3 (CH3). 
MS (CI): m/z (%) = 202 (M++1, 100), 186 (12). 
N-(2-ethynylbenzyl)acetamide (3f) 
Acetic anhydride (1.15 g, 11.29 mmol) was added 
dropwise to a solution of (2-
bromophenyl)methanamine (2.00 g, 10.75 mmol) in 
Et3N (40 mL) at room temperature. The reaction 
mixture was stirred for 12 h until disappearance of 
starting material (TLC, GC-MS monitoring). Excess 
of acetic anhydride was quenched with H2O (40 mL) 
and the mixture was extracted with EtOAc (3 x 10 
mL). The combined organic layers were dried over 
anhydrous Na2SO4, filtered and evaporated under 
vacuum to afford quantitatively N-(2-
bromobenzyl)acetamide (2.44 g) as a white solid. 
mp: 81-82.5 ºC 
1H NMR (250 MHz, CDCl3): δ = 7.51 (d, J = 7.9 Hz, 
1H), 7.34-7.21 (m, 2H), 7.11 (t, J = 7.5 Hz, 1H), 6.62 
(s, 1H), 4.43 (d, J = 6.0 Hz, 2H), 1.99 (s, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 170.2 (C=O), 
137.1 (C), 132.6 (CH), 129.8 (CH), 128.9 (CH), 127.5 
(CH), 123.4 (C), 43.6 (CH2), 22.9 (CH3). 
MS (CI): m/z (%) = 228 (M++1, 100), 171 (15), 148 
(14). 
In a flame-dried round-bottomed flask under Ar was 
suspended N-(2-bromobenzyl)acetamide (2.37 g, 
10.44 mmol), PdCl2 (0.28 g, 1.57), Cu(OAc)2 (0.38 g, 
2.09 mmol), PPh3 (1.37 g, 5.22 mmol) in Et3N (100 
mL) and trimethylsilylacetylene (2.95 g, 2.95 mL, 
20.88 mmol). The reaction mixture was stirred at 90 
ºC for 17 h until disappearance of starting material 
(TLC, GC-MS monitoring). The reaction mixture was 
filtered through silica gel using EtOAc as eluent. The 
filtrate was evaporated under vacuum and the residue 
was purified by flash column chromatography through 
silica gel using a 1:1 mixture of EtOAc/Hex as eluent 
to give N-{2-
[(trimethylsilyl)ethynyl)benzyl}acetamide (1.10 g, 
43%) as a brown solid. 
1H NMR (250 MHz, CDCl3): δ = 7.45 (d, J = 6.7 Hz, 
1H), 7.31-7.18 (m, 3H), 6.35 (s, 1H), 4.54 (d, J = 5.9 
Hz, 2H), 1.98 (s, 3H), 0.27 (s, 9H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 169.9 (C=O), 
140.1 (C), 132.4 (CH), 128.8 (CH), 128.1 (CH), 127.1 
(CH), 122.0 (C), 102.7 (C), 99.3 (C), 42.2 (CH2), 23.0 
(CH3), -0.2 (3 x CH3). 
MS (CI): m/z (%) = 246 (M++1, 100), 230 (33), 204 
(31). 
The general desilylation procedure was followed 
using N-{2-[(trimethylsilyl)ethynyl]benzyl}acetamide 
(0.22 g, 1.63 mmol), a solution of TBAF in THF (1M, 
1.63 mL) and THF (15 mL). Upon completion (10 
min) and work-up, the residue was purified by flash 
column chromatography through silica gel using a 7:3 
mixture of EtOAc/Hex as eluent to give 3f (0.21 g, 
75%) as a yellowish solid. 
1H NMR (250 MHz, CDCl3): δ = 7.46 (d, J = 7.1 Hz, 
1H), 7.33-7.16 (m, 3H), 6.71 (s, 1H), 4.52 (d, J = 5.9 
Hz, 2H), 3.33 (s, 1H), 1.94 (s, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 170.1 (C=O), 
140.5 (C), 132.6 (CH), 129.0 (CH), 128.0 (CH), 127.0 
(CH), 120.8 (C), 82.0 (CH), 81.2 (C), 41.8 (CH2), 
22.8 (CH3). 




A solution of p-toluenesulfonyl chloride (2.15 g, 11.30 
mL) in Et3N (4.50 mL) was cannulated to a solution 
of (2-bromophenyl)methanamine (2.00 g, 10.76 
mmol) in CH2Cl2 (22 mL) cooled at 0ºC. The reaction 
mixture was stirred for 12 h at room temperature until 
disappearance of starting material (TLC, GC-MS 
monitoring). The reaction was quenched adding H2O 
(20 mL) and then extracted with EtOAc (3 x 10 mL). 
The combined organic layers were dried over 
anhydrous Na2SO4, filtered and evaporated under 
vacuum. The residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to give N-(2-bromobenzyl)-4-
methylbenzenesulfonamide (2.85g, 75%) as a white 
solid. 
1H NMR (500 MHz, CDCl3): δ = 7.71 (d, J = 8.2 Hz, 
2H), 7.43 (d, J = 7.8 Hz, 1H), 7.30 (d, J = 7.5 Hz, 
1H), 7.23 (d, J = 8.2 Hz, 2H), 7.19 (t, J = 7.5 Hz, 1H), 
7.09 (t, J = 7.8 Hz, 1H), 5.20 (t, J = 6.5 Hz, 1H), 4.21 
(d, J = 6.5 Hz, 2H), 2.39 (s, 3H). 
13C NMR, DEPT (125 MHz, CDCl3): δ = 143.4 (C), 
136.8 (C), 135.5 (C), 132.6 (CH), 130.3 (CH), 129.5 
(2 x CH), 129.4 (CH), 127.6 (CH), 127.0 (2 x CH), 
123.3 (C), 47.3 (CH2), 21.4 (CH3). 
MS (CI): m/z (%) = 340 (M++1, 8), 260 (68), 184 
(100), 155 (23), 139 (19), 91 (77), 77 (25), 65 (22). 
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HRMS-EI: m/z calcd for C14H14NO2SBr [M+]: 
338.9929; found: 338.9914. 
The general Sonogashira cross coupling procedure 2 
was followed using N-(2-bromobenzyl)-4-
methylbenzenesulfonamide (1.44 g, 4.25 mmol), 
Pd(OAc)2 (0.029 g, 0.13 mmol), CuI (0.024 g, 0.13 
mmol), PPh3 (0.056 g, 0.21 mmol), 
trimethylsilylacetylene (0.63 g, 0.90 mL, 3.38 mmol) 
and Et3N (40 mL). Upon completion (8 h) and work-
up, the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to afford 4-methyl-N-{2 
[(trimethylsilyl)ethynyl]benzyl}benzenesulfonamide 
(0.56 g, 37%) as a brown solid. To this solid solved  in 
THF (15 mL) was added a solution of TBAF in THF 
(1M, 2.34 mL) and the resulting solution stirred at 
room temperature. Upon completion (10 min) and 
work-up, the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of EtOAc/Hex as eluent to give 3g (0.28 g, 63%) as a 
brown solid. 
1H NMR (500 MHz, CDCl3): δ = 7.70 (d, J = 8.2 Hz, 
2H), 7.40 (d, J = 7.3 Hz, 1H), 7.25-7.18 (m, 5H), 5.02 
(t, J = 6.2 Hz, 1H), 4.30 (d, J = 6.2 Hz, 2H), 3.20 (s, 
1H), 2.40 (s, 3H). 
13C NMR, DEPT (125 MHz, CDCl3): δ = 143.3 (C), 
138.6 (C), 137.0 (C), 132.9 (CH), 129.5 (2 x CH), 
129.2 (CH), 128.8 (CH), 127.7 (CH), 127.1 (2 x CH), 
121.0 (C), 82.4 (CH), 81.0 (C), 46.0 (CH2), 21.3 
(CH3). 
MS (CI): m/z (%) = 286 (M++1, 100). 
HRMS-EI: m/z calcd for C16H15NO2S [M+]: 
285.0823; found: 285.0828. 
4-Methyl-N-(2-(prop-2-yn-1-
yl)phenyl)benzenesulfonamide (5) 
To a solution of (2-aminophenyl)methanol (1.00 g, 
8.12 mmol) in CH2Cl2 (50 mL) was added MnO2 
(0.70 g, 8.12 mmol) at room temperature. The reaction 
mixture was stirred for 24 h until disappearance of 
starting material (TLC, GC-MS monitoring). The 
mixture was filtered through silica gel using EtOAc as 
eluent. The filtrate was evaporated under vacuum and 
the residue was purified by flash column 
chromatography through silica gel using a 3:7 mixture 
of EtOAc/Hex as eluent to give 2-aminobenzaldehyde 
(0.49g, 50%) as a yellow oil. 
1H NMR (250 MHz, CDCl3): δ = 9.88 (s, 1H), 7.49 
(dd, J = 7.8, 1.4 Hz, 1H), 7.36-7.28 (m, 1H), 6.75 (t, J 
= 7.5 Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 6.10 (s, 2H). 
MS (CI): m/z (%) = 122 (M++1, 100), 94 (6). 
A solution of p-toluenesulfonyl chloride (0.70 g, 3.64 
mmol) in CH2Cl2 (7 mL) was cannulated to a solution 
of 2-aminobenzaldehyde (0.40g, 3.31 mmol) and 
pyridine (0.58 g, 0.60 mL, 7.28 mmol) in CH2Cl2 (10 
mL) cooled at 0 ºC. The reaction mixture was stirred 
for 12 h at room temperature until disappearance of 
starting material (TLC, GC-MS monitoring). The 
reaction was quenched adding H2O (10 mL) and then 
was extracted with EtOAc (3 x 5 mL). The combined 
organic layers were dried over anhydrous Na2SO4, 
filtered and evaporated under vacuum. The residue 
was purified by flash column chromatography through 
silica gel using 1:4 mixture of EtOAc/Hex as eluent to 
give N-(2-formylphenyl)-4-
methylbenzenesulfonamide (0.83 g, 91%) as a brown 
oil. 
1H NMR (250 MHz, CDCl3): δ = 10.79 (s, 1H), 9.83 
(s, 1H), 7.78 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.4 Hz, 
1H), 7.62-7.57 (m, 1H), 7.55-7.47 (m, 1H), 7.27-7.22 
(m, 2H), 7.19-7.11 (m, 1H), 2.37 (s, 3H). 
MS (CI): m/z (%) = 276 (M++1, 50), 248 (20), 155 
(26), 125 (100). 
A 5 M solution of ethynyl magnesium bromide in 
THF (5.60 mL, 2.80 mmol) was added dropwise to a 
solution of N-(2-formylphenyl)-4-
methylbenzenesulfonamide (0.70 g, 2.54 mmol) in 
THF (25 mL) cooled at 0 ºC. The reaction mixture 
was stirred for 7 h at 0 ºC until disappearance of 
starting material(TLC, GC-MS monitoring). The 
mixture was evaporated under vacuum and the residue 
was dissolved in EtOAc (20 mL), washed with brine 
(2 x 10 mL), dried over anhydrous Na2SO4, filtered 
and evaporated under vacuum. The residue was 
purified by flash column chromatography through 
silica gel using a 1:1 mixture of EtOAc/Hex as eluent 
to give N-[2-(1-hydroxyprop-2-yn-1-yl)phenyl]-4-
methylbenzenesulfonamide (0.72 g, 94%) as a 
yellowish oil. 
1H NMR (250 MHz, CDCl3): δ = 7.97 (s, 1H), 7.65 (d, 
J = 8.2 Hz, 2H), 7.51 (d, J = 7.6 Hz, 1H), 7.33-7.09 
(m, 5H), 5.34 (d, J = 2.0 Hz, 1H), 3.69 (s, 1H), 2.64 
(d, J = 2.2 Hz, 1H), 2.36 (s, 3H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 143.9 (C), 
136.3 (C), 135.0 (C), 131.2 (C), 129.6 (2 x CH), 129.5 
(CH), 128.7 (CH), 127.1 (2 x CH), 125.5 (CH), 123.2 
(CH), 81.4 (C), 76.3 (CH), 62.2 (CH), 21.4 (CH3). 
A solution of Et3SiH (0.50 g, 0.69 mL, 4.32 mmol) in 
TFA (1 g, 0.67 mL, 8.64 mmol) was slowly added to a 
solution of N-[2-(1-hydroxyprop-2-yn-1-yl)phenyl]-4-
methylbenzenesulfonamide (0.65 g, 2.16 mmol) in 
THF (20 mL). The reaction mixture was stirred for 12 
h at room temperature until disappearance of starting 
material (TLC, GC-MS monitoring). The reaction was 
quenched by adding a saturated solution of NaHCO3 
(15 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were dried over anhydrous 
Na2SO4, filtered and evaporated under vacuum. The 
residue was purified by flash column chromatography 
through silica gel using a 3:7 mixture of EtOAc/Hex 
as eluent to afford 4 (0.32 g, 51%) as a brown oil. 
1H NMR (250 MHz, CDCl3): δ = 7.61 (d, J = 8.2 Hz, 
2H), 7.27-7.15 (m, 6H), 6.99 (s, 1H), 3.24 (d, J = 2.6 
Hz, 2H), 2.39 (s, 3H), 2.04 (s, 1H). 
13C NMR, DEPT (62 MHz, CDCl3): δ = 143.8 (C), 
136.6 (C), 134.2 (C), 130.7 (C), 129.6 (2 x CH), 129.5 
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(CH), 128.0 (CH), 127.0 (2 x CH), 126.8 (CH), 125.9 
(CH), 80.4 (C), 71.8 (CH), 21.6 (CH2), 21.5 (CH3). 
MS (CI): m/z (%) = 286 (M++1, 100), 160 (30), 132 
(94). 
General procedure for the Ru-catalyzed 
heterocyclization reactions 
Aromatic alkynyl amines/amides (1 equiv) were 
added to a suspension of the ruthenium catalyst (10 
mol%) in pyridine (0.15 M) in a flame-dried sealed 
tube under Ar and the reaction mixture was heated at 
90 ºC until the complete consumption of the starting 
material (GC-MS monitoring). The reaction mixture 
was then cooled at room temperature, washed with 
saturated aqueous solution of NH4Cl and extracted 
with diethyl ether (3 x). The combined organic layers 
were dried over anhydrous Na2SO4, filtered and 
evaporated under vacuum. The residue was purified 
by flash column chromatography through silica gel 
using a mixture of EtOAc/Hex as eluent to afford the 
corresponding heterocyclization product. 
1H-indole (2a) 
The general heterocyclization procedure was followed 
using 1a (0.058 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (25 min), the reaction was worked-up and 
the residue was purified by flash column 
chromatography through silica gel using a 1:4 mixture 
of  EtOAc/Hex as eluent to give 2a (0.049 g, 84 %) as 
a yellow solid. 
1H NMR (300 MHz, CDCl3), δ (ppm): 8.02 (s, 1H), 
7.65 (d, J = 7.8 Hz, 1H), 7.34 (d, J = 7.8 Hz, 1H), 
7.21-7.09 (m, 3H), 6.54 (d, J = 2.0 Hz, 1H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 135.7 
(C), 127.8 (C), 124.1 (CH), 121.9 (CH), 120.7 (CH), 
119.8 (CH), 110.9 (CH), 102.5 (CH). 
MS (CI): m/z (%) = 118 (M++1, 100), 91 (14), 77 
(15). 
1-(Methylsulfonyl)-1H-indole (2b) 
The general heterocyclization procedure was followed 
using 1b (0.098 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (40 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:9 mixture of  EtOAc/Hex as eluent 
to give 2b (0.072 g, 73 %) as a yellowish oil. 
1H NMR (250 MHz, CDCl3), δ (ppm): 7.91 (d, J = 8.3 
Hz, 1H), 7.62 (dd, J = 6.9, 1.4 Hz, 1H), 7.43 (d, J = 
3.7 Hz, 1H), 7.39-7.24 (m, 2H), 6.71 (d, J = 3.7 Hz, 
1H), 3.08 (s, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 134.8 
(C), 130.6 (C), 126.1 (CH), 124.8 (CH), 123.5 (CH), 
121.6 (CH), 112.9 (CH), 108.8 (CH), 40.6 (CH3). 
MS (EI, 70 eV): m/z (%) = 195 (M+, 24), 116 (100), 
89 (43), 63 (28). 
HRMS-EI: m/z calcd for C9H9NO2S [M+]: 195.0354; 
found: 195.0354. 
1-Tosyl-1H-indole (2c) 
The general heterocyclization procedure was followed 
using 1c (0.136 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (40 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 2c (0.108 g, 80 %) as a yellowish oil. 
1H NMR (250 MHz, CDCl3), δ (ppm): 7.99 (d, J = 8.1 
Hz, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.59-7.49 (m, 2H), 
7.33-7.18 (m, 4H), 6.65 (d, J = 3.7 Hz, 1H), 2.32 (s, 
3H).  
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 144.9 
(C), 135.3 (C), 134.8 (C), 130.7 (C), 129.8 (2 x CH), 
126.8 (2 x CH), 126.4 (CH), 124.5 (CH), 123.2 (CH), 
121.3 (CH), 113.6 (CH), 109.0 (CH), 21.5 (CH3). 
MS (CI): m/z (%) = 272 (M++1, 8), 271 (72), 180 
(53), 91 (100). 
HRMS-CI: m/z calcd for C15H14NO2S [M++1]: 
272.0745; found: 272.0745. 
5-Nitro-1H-indole (2d) 
The general heterocyclization procedure was followed 
using 1d (0.081 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (20 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 2d (0.058 g, 72 %) as a yellow solid. 
1H NMR (300 MHz, CDCl3), δ (ppm): 8.71 (s, 1H), 
8.62 (s, 1H), 8.12 (d, J = 9.0 Hz, 1H), 7.45 (d, J = 9.0 
Hz, 1H), 7.39 (bs, 1H), 6.74 (s, 1H).  
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 141.9 
(C), 138.8 (C), 127.4 (CH), 127.2 (C), 118.0 (CH), 
117.6 (CH), 111.0 (CH), 105.0 (CH). 
MS (EI, 70 eV): m/z (%) = 162 (M+, 100), 132 (15), 
116 (95), 104 (22), 89 (70), 63 (35). 
HRMS-EI: m/z calcd for C8H6N2O2 [M+]: 162.0429; 
found: 162.0429. 
1H-indole-5-carbonitrile (2e) 
The general heterocyclization procedure was followed 
using 1e (0.071 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (30 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 2e (0.070 g, 98 %) as a yellow solid. 
1H NMR (300 MHz, CDCl3), δ (ppm):  9.10 (s, 1H), 
7.98 (s, 1H), 7.47 (d, J = 8.5 Hz, 1H), 7.39 (dd, J = 
8.5, 1.4 Hz, 1H), 7.34-7.32 (m, 1H), 6.60 (bs, 1H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 137.5 
(C), 128.9 (C), 126.6 (CH), 126.2 (CH), 124.6 (CH), 
121.0 (CN), 112.1 (CH), 103.1 (CH), 102.3 (C). 
MS (EI, 70 eV): m/z (%) = 142 (M+, 100), 115 (36), 
88 (10). 
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HRMS-EI: m/z calcd for C9H6N2 [M+]: 142.0531; 
found: 142.0531. 
Methyl 1H-indole-5-carboxylate (2f) 
The general heterocyclization procedure was followed 
using 1f (0.088 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (30 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of EtOAc/Hex as eluent 
to give 2f (0.086 g, 98 %) as a yellow solid. 
1H NMR (300 MHz, CDCl3), δ (ppm):  8.85 (s, 1H), 
8.43 (s, 1H), 7.89 (dd, J = 8.6, 1.5 Hz, 1H), 7.37 (d, J 
= 8.6 Hz, 1H), 7.23-7.21 (m, 1H), 6.61 (bs, 1H), 3.92 
(s, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 168.4 
(C=O), 138.4 (C), 128.8 (C), 125.9 (CH), 123.7 (CH), 
123.1 (CH), 121.6 (C), 110.8 (CH), 103.7 (CH), 51.8 
(CH3). 
MS (EI, 70 eV): m/z (%) = 175 (M+, 67), 144 (100), 
116 (55), 89 (21), 58 (44). 
HRMS-EI: m/z calcd for C10H9NO2 [M+]: 175.0633; 
found: 175.0633. 
Methyl 1H-indole-6-carboxylate (2g) 
The general heterocyclization procedure was followed 
using 1g (0.088 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (90 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 2g (0.081 g, 92 %) as a yellow solid. 
1H NMR (250 MHz, CDCl3), δ (ppm):  8.70 (bs, 1H), 
8.16 (bs, 1H), 7.82 (dd, J = 8.4, 1.4 Hz, 1H), 7.62 (d, 
J = 8.4 Hz, 1H), 7.32 (t, J = 2.8 Hz 1H), 6.57 (m, 
1H), 3.92 (s, 3H). 
Isoquinolin-1(2H)-one (4b) 
The general heterocyclization procedure was followed 
using 3b (0.072 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (60 min) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:1 mixture of  EtOAc/Hex as eluent 
to give 4b (0.058 g, 80 %) as a yellow solid. 
1H NMR (300 MHz, CDCl3), δ (ppm): 11.49 (s, 1H), 
8.43 (d, J = 8.0 Hz, 1H), 7.68 (t, J = 6.9 Hz, 1H), 
7.59-7.51 (m, 2H), 7.20 (d, J = 7.1 Hz, 1H), 6.58 (d, J 
= 7.1 Hz, 1H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 164.4 
(C=O), 138.1 (C), 132.5 (CH), 127.6 (CH), 127.3 
(CH), 126.8 (CH), 126.2 (CH), 126.1 (C), 106.7 (CH). 
MS (EI, 70 eV): m/z (%) = 145 (M+, 100), 118 (36), 
90 (29). 
HRMS-EI: m/z calcd for C9H7NO [M+]: 145.0528; 
found 145.0528. 
2-Butylisoquinolin-1(2H)-one (4c) 
The general heterocyclization procedure was followed 
using 3c (0.100 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (6 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 4c (0.074 g, 74 %) as a brown oil. 
1H NMR (500 MHz, CDCl3), δ (ppm): 8.44 (d, J = 8.1 
Hz, 1H), 7.64-7.60 (m, 1H), 7.51-7.46 (m, 2H), 7.06 
(d, J = 7.3 Hz, 1H), 6.48 (d, J = 7.3 Hz, 1H), 4.02-
3.98 (m, 2H), 1.80-1.74 (m, 2H), 1.40 (td, J = 14.8, 
7.4 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 162.1 
(C=O), 137.0 (C), 132.0 (CH), 131.7 (CH), 127.8 
(CH), 126.7 (CH), 126.3 (C), 125.8 (CH), 105.8 (CH), 
49.1 (CH2), 31.4 (CH2), 20.0 (CH2), 13.8 (CH3). 
MS (EI, 70 eV): m/z (%) = 202 (M+1, 100), 149 (8), 
123 (16). 
HRMS (ESI): m/z calcd for C13H16NO [M++1]: 
202.1232; found: 202.1226. 
2-Butyl-2H-1,2-benzothiazine 1,1-dioxide (4d) 
The general heterocyclization procedure was followed 
using 3d (0.118 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (6 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 4d (0.072 g, 61 %) as a brown oil. 
1H NMR (400 MHz, CDCl3), δ (ppm): 7.91 (d, J = 7.9 
Hz, 1H), 7.56 (t, J = 7.6 Hz, 1H), 7.47-7.35 (m, 2H), 
6.56 (d, J = 7.9 Hz, 1H), 6.24 (d, J = 7.9 Hz, 1H), 
3.76-3.71 (m, 2H), 1.75-1.67 (m, 2H), 1.35 (dd, J = 
15.1, 7.5 Hz, 2H), 0.92 (t, J = 7.5 Hz, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 133.2 
(C), 131.9 (CH), 131.3 (CH), 131.1(C), 127.3 (CH), 
126.5 (CH), 121.6 (CH), 107.1 (CH), 48.0 (CH2), 32.3 
(CH2), 19.6 (CH2), 13.6 (CH3). 
MS (CI): m/z (%) = 238 (M++1, 100), 182 (6), 174 
(4). 
HRMS (ESI): m/z calcd for C12H16NO2S [M++1]: 
238.0902; found: 238.0896. 
1-(Isoquinolin-2(1H)-yl)ethanone (4f) 
The general heterocyclization procedure was followed 
using 3f (0.086 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (5 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 4f (0.048 g, 56 %) as a yellowish oil. 
1H NMR (250 MHz, CDCl3), δ (ppm): 7.20-7.04 (m, 
4H), 6.65 (d, J = 7.8 Hz, 1H), 5.82 (d, J = 7.8 Hz, 
1H), 4.94 (s, 2H), 2.20 (s, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 168.8 
(C=O), 130.4 (C), 129.4 (C), 127.6 (CH), 127.3 (CH), 
126.0 (CH), 125.9 (CH), 124.6 (CH), 109.6 (CH), 
44.3 (CH2), 21.2 (CH3). 
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MS (CI): m/z (%) = 174 (M++1, 100), 132 (30). 
HRMS (ESI): m/z calcd for C11H12NO [M++1]: 
174.0919; found: 174.0913. 
2-Tosyl-1,2-dihydroisoquinoline (4g) 
The general heterocyclization procedure was followed 
using 3g (0.142 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (4 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 4g (0.116 g, 82 %) as a brown solid. 
1H NMR (250 MHz, CDCl3), δ (ppm): 7.69 (d, J = 8.3 
Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 7.15-7.05 (m, 2H), 
6.98-6.90 (m, 2H), 6.76 (d, J = 7.8 Hz, 1H), 5.83 (d, J 
= 7.8 Hz, 1H), 4.56 (s, 2H), 2.37 (s, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 144.1 
(C), 134.4 (C), 130.4 (C), 129.8 (2 x CH), 128.0 (CH), 
127.3 (C), 127.2 (CH), 127.1 (2 x CH), 126.4 (CH), 
125.5 (CH), 124.4 (CH), 110.0 (CH), 47.1 (CH2), 21.5 
(CH3). 
HRMS-EI: m/z calcd for C16H15NO2S [M+]: 
285.0823; found: 285.0823. 
1-Tosyl-1,4-dihydroquinoline (6) 
The general heterocyclization procedure was followed 
using 5 (0.142 g, 0.50 mmol), CpRuCl(PPh3)2 (0.036 
g, 0.050 mmol) and pyridine (3.30 mL). Upon 
completion (12 h) and work-up, the residue was 
purified by flash column chromatography through 
silica gel using a 1:4 mixture of  EtOAc/Hex as eluent 
to give 6 (0.085 g, 60 %) as a brown oil. 
1H NMR (500 MHz, CDCl3), δ (ppm): 7.81 (d, J = 8.2 
Hz, 1H), 7.44 (d, J = 8.1 Hz, 2H), 7.26-7.22 (m, 1H), 
7.15 (d, J = 8.1 Hz, 3H), 6.89 (d, J = 7.5 Hz, 1H), 
6.71 (d, J = 7.3 Hz, 1H), 5.54-5.49 (m, 1H), 2.73 (d, J 
= 3.6 Hz, 2H), 2.37 (s, 3H). 
13C NMR, DEPT (75 MHz, CDCl3), δ (ppm): 143.9 
(C), 135.5 (C), 134.5 (C), 129.9 (C), 129.3 (2 x CH), 
128.3 (CH), 127.6 (CH), 127.3 (2 x CH), 126.8 (CH), 
126.2 (CH), 124.3 (CH), 116.6 (CH), 26.6 (CH2), 21.6 
(CH3). 
MS (CI): m/z (%) = 286 (M++1, 85), 160 (30), 132 
(100). 
HRMS (ESI): m/z calcd for C16H15NO2SNa [M++Na]: 
308.0721; found: 308.0716. 
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